WYB

2,2'-[(2-chloro-5-cyano-1,3-phenylene)bis(azanediyl)]bis(oxoacetic acid)

Created:	2022-10-24
Last modified:	2023-10-31

Find Related PDB Entry
1 entries where WYB is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	27
Chiral Atom Count	0
Bond Count	27
Aromatic Bond Count	6

2D diagram of WYB

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2,2'-[(2-chloro-5-cyano-1,3-phenylene)bis(azanediyl)]bis(oxoacetic acid)
Synonyms	Lodoxamide
Systematic Name (OpenEye OEToolkits)	2-[[3-(carboxycarbonylamino)-2-chloranyl-5-cyano-phenyl]amino]-2-oxidanylidene-ethanoic acid
Formula	C₁₁ H₆ Cl N₃ O₆
Molecular Weight	311.635
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Clc1c(cc(cc1NC(=O)C(=O)O)C#N)NC(=O)C(=O)O
SMILES	CACTVS	3.385	OC(=O)C(=O)Nc1cc(cc(NC(=O)C(O)=O)c1Cl)C#N
SMILES	OpenEye OEToolkits	2.0.7	c1c(cc(c(c1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N
Canonical SMILES	CACTVS	3.385	OC(=O)C(=O)Nc1cc(cc(NC(=O)C(O)=O)c1Cl)C#N
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1c(cc(c(c1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N
InChI	InChI	1.06	InChI=1S/C11H6ClN3O6/c12-7-5(14-8(16)10(18)19)1-4(3-13)2-6(7)15-9(17)11(20)21/h1-2H,(H,14,16)(H,15,17)(H,18,19)(H,20,21)
InChIKey	InChI	1.06	RVGLGHVJXCETIO-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB06794
Name	Lodoxamide
Groups	approved
Description	Lodoxamide is a mast-cell stabilizer for topical administration into the eye. Mast-cell stabilizers, first one approved being cromolyn sodium, are used in treatment of ocular hypersensitivity reactions such as vernal conjunctivitis. These conditions often require treatment with anti-inflammatory medications such as ophthalmic NSAIDs or topical steroids which may cause systemic or toxic effects long-term. Although less effective than topical steroids at decreasing inflammation, mast-cell stabilizers offer another treatment option and exhibit minimal adverse effects. Lodoxamide is marketed under the brand name Alomide by Alcon.
Synonyms	Lodoxamida N,N'-(2-chloro-5-cyano-m-phenylene)dioxamate Lodoxamide Lodoxamide tromethamine
Brand Names	Alomide
Indication	Indicated in the treatment of the ocular disorders referred to by the terms vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.
Categories	Acids, Aldehydic Alcohols Amino Acids Amino Acids, Peptides, and Proteins Anti-Allergic Agents Antioxidants Decongestants and Antiallergics Decreased Histamine Release Glycols Glyoxylates Histamine Agents Mast Cell Stabilizers Neurotransmitter Agents Ophthalmologicals Propylene Glycols Sensory Organs
ATC-Code	S01GX05
CAS number	53882-12-5

Related Resource References

Resource Name	Reference
PubChem	44564
ChEMBL	CHEMBL1201266
ChEBI	CHEBI:135333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.